Accelerated publication: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65

Biochemical Journal

Volumn 460, Issue 1, 2014, Pages 127-139

  Kazlauskaite, Agne ^a   Kondapalli, Chandana ^a   Gourlay, Robert ^a   Campbell, David G ^a   Ritorto, Maria Stella ^a   Hofmann, Kay ^b   Alessi, Dario R ^a   Knebel, Axel ^a   Trost, Matthias ^a   Muqit, Miratul M K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Parkin; Parkinson's disease; Phosphorylation; PTEN (phosphatase and tensin homologue deleted on chromosome 10) induced putative kinase 1 (PINK1); Ubiquitin

Indexed keywords

PARKIN; PINK1 PROTEIN; PROTEIN; SERINE; SERINE 65; TRIFLUOROACETIC ACID; UBIQUITIN; UNCLASSIFIED DRUG; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE; UBIQUITIN PROTEIN LIGASE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ALIGNMENT; STOICHIOMETRY; UBIQUITINATION; AMINO ACID SEQUENCE; GENETICS; HEK293 CELL LINE; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PHYSIOLOGY;

AMINO ACID SEQUENCE; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN KINASES; SERINE; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84899421556     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140334     Document Type: Article

References (41)

1. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 CrossRef PubMed
2. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G. et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160 CrossRef PubMed
3. Lucking, C. B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denefle, P., Wood, N. W. et al. (2000) Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342, 1560-1567 CrossRef
4. Khan, N. L., Graham, E., Critchley, P., Schrag, A. E., Wood, N. W., Lees, A. J., Bhatia, K. P. and Quinn, N. (2003) Parkin disease: a phenotypic study of a large case series. Brain 126, 1279-1292 CrossRef PubMed
5. Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J. and Piccini, P. (2002) Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann. Neurol. 52, 849-853 CrossRef PubMed
6. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A. and Guo, M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166 CrossRef PubMed
7. Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J. M. and Chung, J. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 1157-1161 CrossRef PubMed
8. Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J. W., Yang, L., Beal, M. F., Vogel, H. and Lu, B. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U.S.A. 103, 10793-10798 CrossRef PubMed
9. Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y. S., Saiki, S., Kawajiri, S., Sato, F. et al. (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211-221 CrossRef PubMed
10. Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D. F., Gautier, C. A., Shen, J., Cookson, M. R. and Youle, R. J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298 CrossRef PubMed
11. Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S. et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. U.S.A. 107, 378-383 CrossRef PubMed
12. Geisler, S., Holmstrom, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J. and Springer, W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12, 119-131 CrossRef PubMed
13. Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H. I., Campbell, D. G., Gourlay, R., Burchell, L., Walden, H., Macartney, T. J., Deak, M. et al. (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2, 120080 CrossRef PubMed
14. Riley, B. E., Lougheed, J. C., Callaway, K., Velasquez, M., Brecht, E., Nguyen, L., Shaler, T., Walker, D., Yang, Y., Regnstrom, K. et al. (2013) Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun. 4, 1982 CrossRef PubMed
15. Wauer, T. and Komander, D. (2013) Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32, 2099-2112 CrossRef PubMed
16. Trempe, J. F., Sauve, V., Grenier, K., Seirafi, M., Tang, M. Y., Menade, M., Al-Abdul-Wahid, S., Krett, J., Wong, K., Kozlov, G. et al. (2013) Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451-1455 CrossRef PubMed
17. Yamano, K. and Youle, R. J. (2013) PINK1 is degraded through the N-end rule pathway. Autophagy 9, 1758-1769 CrossRef PubMed
18. Ubersax, J. A. and Ferrell, Jr, J. E. (2007) Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 8, 530-541 CrossRef PubMed
19. Thingholm, T. E., Jorgensen, T. J., Jensen, O. N. and Larsen, M. R. (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 1, 1929-1935 CrossRef PubMed
20. Trost, M., English, L., Lemieux, S., Courcelles, M., Desjardins, M. and Thibault, P. (2009) The phagosomal proteome in interferon-γ -activated macrophages. Immunity 30, 143-154 CrossRef PubMed
21. Cox, J. and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372 CrossRef PubMed
22. Woodroof, H. I., Pogson, J. H., Begley, M., Cantley, L. C., Deak, M., Campbell, D. G., van Aalten, D. M. F., Whitworth, A. J., Alessi, D. R. and Muqit, M. M. K. (2011) Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations. Open Biology. 1, 110012 CrossRef PubMed
23. Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S. and Walden, H. (2011) Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867 CrossRef PubMed
24. Whitby, F. G., Xia, G., Pickart, C. M. and Hill, C. P. (1998) Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J. Biol. Chem. 273, 34983-34991 CrossRef PubMed
25. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315 CrossRef PubMed
26. Campbell, D. G. and Morrice, N. A. (2002) Identification of protein phosphorylation sites by a combination of mass spectrometry and solid phase Edman sequencing. J. Biomol. Tech. 13, 119-130 PubMed
27. Kazlauskaite, A., Kelly, V., Johnson, C., Baillie, C., Hastie, C. J., Peggie, M., Macartney, T., Woodroof, H. I., Alessi, D. R., Pedrioli, P. G. and Muqit, M. M. (2014) Phosphorylation of Parkin at Serine65 is essential for activation: elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity. Open Biol. 4, 130213 CrossRef PubMed
28. Burchell, L., Chaugule, V. K. and Walden, H. (2012) Small, N-terminal tags activate parkin e3 ubiquitin ligase activity by disrupting its autoinhibited conformation. PLoS ONE 7, e34748 CrossRef PubMed
29. Tomoo, K., Mukai, Y., In, Y., Miyagawa, H., Kitamura, K., Yamano, A., Shindo, H. and Ishida, T. (2008) Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin. Biochim. Biophys. Acta 1784, 1059-1067 CrossRef PubMed
30. Tashiro, M., Okubo, S., Shimotakahara, S., Hatanaka, H., Yasuda, H., Kainosho, M., Yokoyama, S. and Shindo, H. (2003) NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson's disease. J. Biomol. NMR 25, 153-156 CrossRef PubMed
31. Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., Yokosawa, H., Hattori, N., Mizuno, Y. et al. (2003) Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301-306 CrossRef PubMed
32. Trempe, J. F., Chen, C. X., Grenier, K., Camacho, E. M., Kozlov, G., McPherson, P. S., Gehring, K. and Fon, E. A. (2009) SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination. Mol. Cell 36, 1034-1047 CrossRef PubMed
33. Pearce, L. R., Komander, D. and Alessi, D. R. (2010) The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9-22 CrossRef PubMed
34. Dou, H., Buetow, L., Sibbet, G. J., Cameron, K. and Huang, D. T. (2013) Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3. Nat. Struct. Mol. Biol. 20, 982-986 CrossRef PubMed
35. Clark, K., Nanda, S. and Cohen, P. (2013) Molecular control of the NEMO family of ubiquitin-binding proteins. Nat. Rev. Mol. Cell Biol. 14, 673-685 CrossRef PubMed
36. Swaminathan, G. and Tsygankov, A. Y. (2006) The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell. Physiol. 209, 21-43 CrossRef PubMed
37. Lee, H. J., Na, K., Kwon, M. S., Kim, H., Kim, K. S. and Paik, Y. K. (2009) Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen. Proteomics 9, 3395-3408 CrossRef PubMed
38. Malik, R., Lenobel, R., Santamaria, A., Ries, A., Nigg, E. A. and Korner, R. (2009) Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J. Proteome Res. 8, 4553-4563 CrossRef PubMed
39. Bennetzen, M. V., Larsen, D. H., Bunkenborg, J., Bartek, J., Lukas, J. and Andersen, J. S. (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell. Proteomics 9, 1314-1323 CrossRef PubMed
40. Gu, T. L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., Wang, Y., Deng, G., Zhu, L., Tan, Z. et al. (2011) Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS ONE 6, e15640 CrossRef PubMed
41. Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J. and Brownell, J. E. (2011) Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat. Rev. Drug Discovery 10, 29-46 CrossRef